We are thrilled to announce that Aitia will be participating in the highly anticipated Aspen Ideas: Health conference. Our CEO, Colin Hill, will be taking the stage on a thought-provoking panel titled “Open to Debate: Is the FDA too Cautious?” alongside distinguished panelist Peter Lurie, President and Executive Director of the Center for Science in the Public Interest, and moderated by John Donvan, correspondent ABC News.
At Aitia, we are passionate about fostering open discussions and driving meaningful conversations within the healthcare industry. Our CEO’s presence on this panel is a testament to our commitment to addressing critical topics that impact the lives of millions of individuals.
During the panel, Colin will share valuable insights and engage in a dynamic exchange of ideas about the cautiousness of the FDA. This engaging discussion will explore the balance between ensuring public safety and facilitating timely access to innovative therapies. By analyzing the regulatory landscape, exploring potential improvements, and considering different perspectives, this panel aims to shed light on the FDA’s role in driving medical advancements.
We invite you to join us at Aspen Ideas: Health on June 23rd at 9am ET, and be a part of this captivating panel discussion.
More information on Aspen Ideas: Health here.